|
|
 |
Substance-using
Women and Drug-exposed Infants:
Module Two - Other Drugs |
|
|
III. Hallucinogens
| A. |
Lysergic acid diethylamide (LSD) |
|
| 1. |
Never positively linked to birth defects or
chromosomal damage |
| 2. |
Associated with an increased rate of spontaneous
abortion |
|
| B. |
Phencyclidine (PCP) |
|
| 1. |
PCP users are very often polydrug abusers |
| 2. |
Effects on the neonate |
|
| a. |
Increased state lability |
| b. |
Decreased consolability |
| c. |
PCP withdrawal syndrome |
| d. |
Jitteriness |
| e. |
Poor visual coordination |
| f. |
Abnormal muscle tension |
|
|
|
|
 University of Nevada, Reno
For information: CASAT
Page last updated May 05, 2001
|
